Ontology highlight
ABSTRACT: Background
Colorectal adenoma (CA), especially high-risk CA (HRCA), is a precancerous lesion with high prevalence and recurrence rate and accounts for about 90% incidence of sporadic colorectal cancer cases worldwide. Currently, recurrent CA can only be treated with repeated invasive polypectomies, while safe and promising pharmaceutical invention strategies are still missing due to the lack of reliable in vitro model for CA-related drug screening.Methods
We have established a large-scale patient-derived high-risk colorectal adenoma organoid (HRCA-PDO) biobank containing 37 PDO lines derived from 33 patients and then conducted a series of high-throughput and high-content HRCA drug screening.Results
We established the primary culture system with the non-WNT3a medium
SUBMITTER: Luo Z
PROVIDER: S-EPMC10478412 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature